Literature DB >> 11911880

How do 14-3-3 proteins work?-- Gatekeeper phosphorylation and the molecular anvil hypothesis.

Michael B Yaffe1.   

Abstract

14-3-3 proteins were the first signaling molecules to be identified as discrete phosphoserine/threonine binding modules. This family of proteins, which includes seven isotypes in human cells and up to 15 in plants, plays critical roles in cell signaling events that control progress through the cell cycle, transcriptional alterations in response to environmental cues, and programmed cell death. Despite over 30 years of research, distinct roles for most isotypes remain unknown. Though 14-3-3 proteins perform different functions for different ligands, general mechanisms of 14-3-3 action include changes in activity of bound ligands, altered association of bound ligands with other cellular components, and changes in intracellular localization of 14-3-3-bound cargo. We present a speculative model where binding of 14-3-3 to multiple sites on some ligands results in global ligand conformational changes that mediate their biological effects. For these multi-site ligands, one binding site is likely to function as a 'gatekeeper' whose phosphorylation is necessary for 14-3-3 binding but may not always be sufficient for full biological activity. If correct, then 14-3-3 may prove to be a bona fide phosphodependent signaling chaperone.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11911880     DOI: 10.1016/s0014-5793(01)03288-4

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  213 in total

1.  Structural view of a fungal toxin acting on a 14-3-3 regulatory complex.

Authors:  Martin Würtele; Christian Jelich-Ottmann; Alfred Wittinghofer; Claudia Oecking
Journal:  EMBO J       Date:  2003-03-03       Impact factor: 11.598

2.  Cables1 complex couples survival signaling to the cell death machinery.

Authors:  Zhi Shi; Hae Ryon Park; Yuhong Du; Zijian Li; Kejun Cheng; Shi-Yong Sun; Zenggang Li; Haian Fu; Fadlo R Khuri
Journal:  Cancer Res       Date:  2014-10-31       Impact factor: 12.701

3.  A protein-domain microarray identifies novel protein-protein interactions.

Authors:  Alexsandra Espejo; Jocelyn Côté; Andrzej Bednarek; Stephane Richard; Mark T Bedford
Journal:  Biochem J       Date:  2002-11-01       Impact factor: 3.857

Review 4.  Functional specificity in 14-3-3 isoform interactions through dimer formation and phosphorylation. Chromosome location of mammalian isoforms and variants.

Authors:  Alastair Aitken
Journal:  Plant Mol Biol       Date:  2002-12       Impact factor: 4.076

5.  Phosphoregulators: protein kinases and protein phosphatases of mouse.

Authors:  Alistair R R Forrest; Timothy Ravasi; Darrin Taylor; Thomas Huber; David A Hume; Sean Grimmond
Journal:  Genome Res       Date:  2003-06       Impact factor: 9.043

Review 6.  ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions.

Authors:  Philippe P Roux; John Blenis
Journal:  Microbiol Mol Biol Rev       Date:  2004-06       Impact factor: 11.056

Review 7.  Dynamic interactions between 14-3-3 proteins and phosphoproteins regulate diverse cellular processes.

Authors:  Carol Mackintosh
Journal:  Biochem J       Date:  2004-07-15       Impact factor: 3.857

8.  14-3-3 proteins mediate inhibitory effects of cAMP on salt-inducible kinases (SIKs).

Authors:  Tim Sonntag; Joan M Vaughan; Marc Montminy
Journal:  FEBS J       Date:  2018-01-09       Impact factor: 5.542

9.  Phosphorylation-dependent binding of 14-3-3 terminates signalling by the Gab2 docking protein.

Authors:  Tilman Brummer; Mark Larance; Maria Teresa Herrera Abreu; Ruth J Lyons; Paul Timpson; Christoph H Emmerich; Emmy D G Fleuren; Gillian M Lehrbach; Daniel Schramek; Michael Guilhaus; David E James; Roger J Daly
Journal:  EMBO J       Date:  2008-09-03       Impact factor: 11.598

10.  Subcellular targeting of p33ING1b by phosphorylation-dependent 14-3-3 binding regulates p21WAF1 expression.

Authors:  Wei Gong; Michael Russell; Keiko Suzuki; Karl Riabowol
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.